Big Pharma Needs A Better Business Model, Not More Legislation

Big Pharma Needs A Better Business Model, Not More Legislation

Source: 
Forbes
snippet: 

When the Trump administration dropped the drug rebate rule it introduced back in January – a rule that intended to prohibit pharmacy benefit managers (PBMs) from pocketing some of the rebates they should be passing along to patients – the decision sent shockwaves through the healthcare industry, particularly the pharma sector.